Gastric plasmacytoma: a rare cause of upper gastrointestinal bleeding.

A 43-year-old female presented to our department with hemoglobin of 3.4 g/dl. She denied gastrointestinal bleeding or weight loss. An upper endoscopy revealed an ulcerative lesion on the greater curvature of the gastric body with two visible clots. Two hemoclips were needed to attain hemostasis, as one of the biopsies of the tumor caused active spurting bleeding. An abdominal computed tomography (CT) demonstrated a well-circumscribed intramural mass arising in the gastric wall, measuring 65 x 50 x 90 mm, with marked internal vascularity and extraluminal component associated. The biopsies identified areas of mature and immature plasmocytes.

Chronic diarrhea due to autoimmune enteropathy.

Chronic diarrhea is a common symptom seen in the Gastroenterology clinic. Occasionally, the diagnosis is a real challenge as there are multiple entities with unremitting diarrhea as a symptom. Herein, we present a patient affected with intractable diarrhea who was transferred to our department. After many laboratory, endoscopy and radiological tests, she was diagnosed with autoimmune enteropathy (AE) and achieved clinical remission with corticosteroids and azathioprine.

Benign non-carcinoid neoplasms of the cecal appendix: presentation of 36 cases during the last 17 years in a third level hospital.

BACKGROUND: The tumors of the cecal appendix are a rare and heterogeneous group of neoplasms with variable prognosis and evolution, its incidence is very low. Mucinous tumors are defined as a dilated cecal appendix due to an abnormal accumulation of mucin, which may be benign or malign. Within these we find the mucoceles, which according to the latest consensus and classifications no longer include them. In this article we describe our experience in these tumors, we also propose a group to include the mucoceles and we review the literature. METHOD: Descriptive and retrospective study, analyzing all the surgical pieces of cecal appendix during the last 17 years. RESULTS: We analyzed 4910 surgical pieces. 36 were included in the group of non-carcinoid benign epithelial neoplasms (NEBNC), in this group 16 were low-grade mucinous neoplasms, 14 mucoceles and 6 tubular adenomas. The most frequent presentation's form was simulating an acute appendicitis. Surgical treatment was performed by open approach in 22 cases and by laparoscopic approach in 14 cases. CONCLUSIONS: Symptomatic NEBNC can simulate acute appendicitis but in people with a higher mean age, so this diagnostic should be considered in older patients with nonspecific imaging tests. The recommended treatment is always surgical and it can be possible by laparoscopic approach.

ANTECEDENTES: Las tumoraciones del apéndice cecal son un grupo raro y heterogéneo de neoplasias con evolución y pronóstico variables, y tienen una incidencia muy baja. Las tumoraciones mucinosas se definen como aquellas con un apéndice cecal dilatado debido a una acumulación anormal de mucina en su interior; pueden ser benignas o malignas. Dentro de ellas se encuentran los mucoceles, que según los últimos consensos y clasificaciones ya no los incluyen. En este artículo se describe la experiencia de los autores en estas tumoraciones y se propone un grupo en el que incluir los mucoceles; además, se hace una revisión de la literatura. MÉTODO: Estudio descriptivo y retrospectivo en el que se analizan todas las piezas quirúrgicas de apéndice cecal durante los últimos 17 años. RESULTADOS: Se analizaron 4910 piezas quirúrgicas. De ellas, 36 fueron incluidas en el grupo de neoplasias epiteliales benignas no carcinoides (NEBNC): 16 fueron neoplasias mucinosas de bajo grado, 14 mucoceles y 6 adenomas tubulares. La forma de presentación más frecuente fue simulando una apendicitis aguda. El tratamiento quirúrgico fue mediante abordaje abierto en 22 casos y laparoscópico en 14. CONCLUSIONES: Las NEBNC sintomáticas pueden simular cuadros de apendicitis aguda, pero en personas con una mayor edad media, por lo que hay que considerar esta posibilidad diagnóstica en pacientes mayores con pruebas de imagen inespecíficas. El tratamiento recomendable es siempre quirúrgico, y resulta viable su realización mediante abordaje laparoscópico.

Necrosis cutánea secundaria a terlipresina, un raro pero grave efecto secundario. Reporte de un caso y revisión de la literatura / Cutaneous necrosis secondary to terlipressin therapy. A rare but serious side effect. Case report and literature review

La terlipresina es un análogo de la vasopresina, utilizado tanto en el tratamiento de la hemorragia por varices esofágicas como en el síndrome hepatorrenal. En general es un fármaco seguro, con efectos secundarios leves. Sin embargo, en ocasiones pueden ocurrir complicaciones isquémicas potencialmente graves, como la necrosis cutánea, que es necesario reconocer de forma precoz para realizar la retirada inmediata del fármaco. Presentamos el caso de una paciente que presentó necrosis cutánea extensa secundaria a la administración de terlipresina, y realizamos una revisión de los casos publicados, describiendo sus características, posibles factores de riesgo, localización de las lesiones, dosis recibida, forma de administración y posibles tratamientos (AU)

Terlipressin is a vasopressin analogue used in esophageal variceal bleeding and hepatorenal syndrome management. It is a safe drug with mild secondary effects. However, potentially serious ischemic complications may occur, such as cutaneous necrosis. It is useful to recognize these events early, in order to withdraw terlipressin and introduce other adjuvant drugs if needed. We report a detailed case of cutaneous necrosis secondary to terlipressin administration and present a case review of patients, describing their characteristics, risk factors, lesion locations, doses, methods of administration and possible treatments (AU)

Cutaneous necrosis secondary to terlipressin therapy. A rare but serious side effect. Case report and literature review.

Terlipressin is a vasopressin analogue used in esophageal variceal bleeding and hepatorenal syndrome management. It is a safe drug with mild secondary effects. However, potentially serious ischemic complications may occur, such as cutaneous necrosis. It is useful to recognize these events early, in order to withdraw terlipressin and introduce other adjuvant drugs if needed. We report a detailed case of cutaneous necrosis secondary to terlipressin administration and present a case review of patients, describing their characteristics, risk factors, lesion locations, doses, methods of administration and possible treatments.